Clinical Trial Update: Depression and Fatigue in MS Patients Treated With Betaferon.

View source ↗

Summary

A completed clinical trial evaluated depression and fatigue in multiple sclerosis patients treated with Betaferon (interferon beta-1b) sponsored by Bayer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Betaferon (interferon beta-1b)

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis | Status: COMPLETED